Explore the latest developments in Cell and Gene Therapy
Explore the latest developments in Cell and Gene Therapy with MilliporeSigma!
Plan to attend our presentations on Tuesday, May 11th:
- A Platform Standard for Viral Vector Manufacturing and Commercialization
- 11:15am - 12:00pm - Exhibitor Showcase
- Biosafety in Gene Therapy: Applying the Latest Regulatory Guidance for RCL Testing
- 5:15pm - 5:30pm - Tools & Technology Forum
Be sure to also explore our Cell and Gene Therapy 3D booth experience to learn more about our Cell and Gene Therapy capabilities.
We’re giving shape to cell and gene therapy development every day. We bring 30+ years of expertise, and a global organization to integrate leading manufacturing technologies with process development, scale-up, safety testing, and the regulatory experience to meet your therapy’s needs.
We have more experience in this area than almost anyone else in the industry. We were the first gene therapy CDMO to produce commercial product following successful regulatory inspection. Our products and services include optimized manufacturing platforms, media and reagents, manufacturing, biosafety and characterization testing, as well as process development services.
MilliporeSigma, a life science leader, is a business of Merck KgaA, Darmstadt, Germany.